These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy. Lichterfeld M; Wöhrmann A; Schmeisser N; Fätkenheuer G; Salzberger B; Wyen C; Schmitz K; Sauerbruch T; Rockstroh JK Eur J Med Res; 2003 Feb; 8(2):56-60. PubMed ID: 12626282 [TBL] [Abstract][Full Text] [Related]
5. Rescue me. Simmons P Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705 [TBL] [Abstract][Full Text] [Related]
6. ICAAC and Hamburg: Part 1. Schmuddelwetter or, rating protease inhibitors on the pass/fail system. Mascolini M J Int Assoc Physicians AIDS Care; 1997 Dec; 3(12):29-37. PubMed ID: 11364943 [TBL] [Abstract][Full Text] [Related]
7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
8. Nelfinavir is number 4 -- but should it bat cleanup, or lead off? Mascolini M J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427 [TBL] [Abstract][Full Text] [Related]
10. Simplifying drug regimens. HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353 [TBL] [Abstract][Full Text] [Related]
11. Long-term strategies: should some patients wait to start protease inhibitors? Interview with Keith Henry, M.D. Interview by John S. James. Henry K AIDS Treat News; 1997 Oct; (No 281):1, 3-6. PubMed ID: 11364791 [TBL] [Abstract][Full Text] [Related]